BIO CEO: Presenter Resource Center

  • Recommend
  • Tweet
  • Print
  • Email

Deadlines   |   Presenter Toolkit   |   Registration Instructions   |   Media Toolkit

About Company Presentations

The 15th Annual BIO CEO & Investor Conference features presentations by over 130 leading biotechnology and pharmaceutical companies, as well as a number of nonprofit and venture philanthropy organizations. Last year we not only scheduled over 1200+ Partnering Meetings, but also opened additional company presentation slots as we were sold out weeks before the conference!

Presenting Companies are hand-selected for the event, and consist of a selection of mid- to large-cap established public companies from around the globe, who typically have a clinical stage program centered around therapeutics, molecular diagnostics, or a platform technology, as well as an upcoming clinical, regulatory, or corporate catalyst. This year will also feature 13-minute private company presentations, for established companies past their Series B round and who have raised >$25M. The typical audience for a company presentation features public and private equity investors, as well as industry analysts, investment bankers and senior biotechnology executives.

If you've been invited to present, confirm your presentation early to guarantee your spot! We are also accepting applications, submit one today!


Upcoming Deadlines

  • Registration: Now Open!
  • Early-Rate Registration Discount: Tuesday, December 18th, 2012
  • One-on-One Partnering: Now Open!
  • BIO CEO Scheduling Begins: Tuesday, January 22nd, 2013
  • The Waldorf Astoria Room Discount: Monday, January 21th, 2013
    • $285/night +tax - See details here.
  • Investor Kits to Arrive at BIO's Headquarters by: Friday, January 25th, 2013
  • Sign-Up for Webcasting at: http://www.veracast.com/bio/ceoinvestor2013/webcast-order-form.cfm
  • Questions about Webcasting: Email bio@veracast.com

 

Presenter Toolkit

More information coming soon. Check back for the following items:

  • Presenter Checklist:
    Important deadlines regarding your presentation and Partnering.
  • Presentation Details & Guidelines:
    Logistics to ensure your presentation goes smoothly.
  • Webcasting Information:
    Those interested will have the option of webcasting their presentation for an additional fee. You may sign up at: http://www.veracast.com/bio/ceoinvestor2013/webcast-order-form.cfm
    • Early Bird Registration for Webcasting: Friday, February 8th, 2013
  • Investor Kits:
    All Investor Kits should be shipped to BIO's headquarters and not the Waldorf Astoria. Please email sbehan@bio.org to notify us that you will be sending materials. You will then receive a shipping form and due date. We cannot guarantee their display if shipped directly to The Waldorf or sent to BIO without notification.
  • BIO CEO & Investor Conference Presentation Title Slide:
    Download the BIO CEO PowerPoint template to use for your presentation: Here.
     

Registration Instructions

Presenters can choose from two Registration Packages for the event.

The Presenter Group Package includes all presentation and registration fees for three people. This package is available for both private companies and public companies.

The Individual Registration option allows you to register your Presenter and pay your company's presentation fee. It also allows for one additional registration (separate fee applies). You will find the breakdown of fees for both private companies and public companies on this page.

ALL presenters must be issued codes in order to begin Registration. Those who have confirmed their presentation should email their package selection and number of attendees to sbehan@bio.org.

Other registration questions? Find registration options for investors and other companies and organizations here.
 

Media Toolkit

More information coming soon. Check back for the following items:

  • Press Release Template: Here
  • Interview Opportunities: For more information, please email Abigail at ahirsch@bio.org
  • Registered Media List - Late January

 

Coverage at Last Year's Event

The BIO CEO & Investor Conference is a must-attend event for reporters covering the business of biotech and remains a widely-publicized event in the media. Last year’s event generated more than 50 million media impressions and attracted more than 60 reporters.

Numerous top tier and trade outlets typically cover the event, including BioWorld, Bloomberg, CNBC, Fierce Biotech, In Vivo, Pink Sheet, Reuters, and The Street. Additionally, numerous reporters attend the event to identify future story opportunities. Outlets that attended last year includedChemical & Engineering News, Merger Market, Forbes, Nature Biotechnology, The Economist, The Deal and the Wall Street Journal.

Coverage focused on the overall state-of-the-industry, policy issues, business development, and company news. Headlines from the 2012 event included the following:

  • BIO Survey Says Investors Express More Optimism for Biotech Companies, Bloomberg, February 24,2012
  • Biotech Investing: Sunny Side of the Street? Dark Side of the Moon?, BioWorld, February 21,2012
  • Innovative Drug Development: Kalydeco Provides A Paradigm, FDA’s Spielberg Says, Elsevier, February 20,2012
  • Hep C drug deal frenzy can’t be slowed by growing doubts, FierceBiotech, February 15, 2012
  • Pfizer says its drug is best hope vs. Alzheimer’s, Reuters, February 14, 2012